PD-1 Inhibitor Drugs Market Surges with Expanding Immunotherapy Applications, Set to Cross $201.5 Billion by 2035 | Latest Report by TMR
04 mars 2025 07h09 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. – , March 04, 2025 (GLOBE NEWSWIRE) -- The Global PD-1 Inhibitor Drugs Market, valued at US$ 41.4 billion in 2024, is set for...
Don’t Kidney Yourself: The Urology Care Foundation is Encouraging You to Be Proactive for National Kidney Month
28 févr. 2025 10h05 HE
|
Urology Care Foundation
BALTIMORE, Feb. 28, 2025 (GLOBE NEWSWIRE) -- March is National Kidney Month, and the Urology Care Foundation, the official foundation of the American Urological Association (AUA), doesn’t want you...
Interventional Oncology Research Report 2025: Devices & Consumables, Procedures, Cancer, End User Market Analysis and Forecasts 2024-2029
27 févr. 2025 11h08 HE
|
Research and Markets
Dublin, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The "Interventional Oncology Market by Devices & Consumables (RF, Microwave, Cryoablation. Embolization), Procedures (Thermal Ablation, Non-Thermal...
Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer
04 juin 2024 10h50 HE
|
The Wistar Institute
PHILADELPHIA, PA, June 04, 2024 (GLOBE NEWSWIRE) -- Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only...
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
28 mars 2024 15h22 HE
|
AVEO Pharmaceuticals, Inc.
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from world-renowned...
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
25 mars 2024 08h10 HE
|
AVEO Pharmaceuticals, Inc.
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from...
Global Interventional Oncology Market Anticipates Explosive Growth, Forecasted at $8.06 Billion by 2034 - Regional Insights for Products, Cancer Types, and End-users
12 mars 2024 12h39 HE
|
Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Interventional Oncology Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist
06 févr. 2024 08h10 HE
|
AVEO Pharmaceuticals, Inc.
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib
Oncology Nutrition Market Experiences Growth with Rise in Personalized and Immuno-nutrition Trends
22 janv. 2024 21h28 HE
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Nutrition Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The recent comprehensive analysis within...
Interventional Oncology Market is Expected to Reach $2.9 billion | MarketsandMarkets.
12 avr. 2023 09h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, April 12, 2023 (GLOBE NEWSWIRE) -- The interventional oncology industry is expected to experience significant growth in the coming years, as new technologies and treatments are developed...